Sino Harbour Holdings Group Limited (the “Group”), formerly known as Sino Harbour Property Group Limited, is an experienced property developer focusing on the development of properties in tiers 2 and 3 cities in the PRC, with headquarter in Hong Kong.

While the Group is principally engaged in property development business, it has been exploring and seeking new opportunities to broaden revenue and improve profitability. In an effort to diversify its business, the Group changed its name from Sino Harbour Property Group Limited to Sino Harbour Holdings Group Limited. The Group is actively building a first-class pharmaceutical contract research organisation (CRO) development platform in the PRC and has expanded into the stem cell industry.